Holm-Jorgensen Rasmus (CIK 0001950496)

Latest company ownership

ACRV - Acrivon Therapeutics, Inc.

Role: CFO

Shares held

26,088

Last filed at

Feb 19, 2025

Confidence Score

50.0

2025Q4

Confidence Score History

2023Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Feb 14, 2025	Feb 19, 2025	Acrivon Therapeutics, Inc.	CFO	Sell	47.5	-434	-1.64%	✗	$2.4K
Nov 14, 2024	Nov 18, 2024	Acrivon Therapeutics, Inc.	CFO	Sell	47.5	-368	-1.37%	✗	$2.9K
Aug 14, 2024	Aug 16, 2024	Acrivon Therapeutics, Inc.	CFO	Sell	47.5	-368	-1.35%	✗	$2.6K
May 14, 2024	May 16, 2024	Acrivon Therapeutics, Inc.	CFO	Sell	47.5	-368	-1.33%	✗	$3.1K
Feb 14, 2024	Feb 16, 2024	Acrivon Therapeutics, Inc.	CFO	Sell	47.5	-434	-1.55%	✗	$1.5K
Nov 14, 2023	Nov 16, 2023	Acrivon Therapeutics, Inc.	CFO	Sell	47.5	-1,470	-4.98%	✗	$7.5K